A Review of Updates to NCCN Evidence-based Guidelines in Advanced Ovarian Cancer

Oct 10, 2022 | Ovarian

2) Earn 0.5hr 🆓CE/#CME credit w/ this 🧵! @onc_ce is your ONLY source for serialized #accredited CE/#CME #tweetorials in #oncology. This program is supported by an educational grant from GSK plc and is intended for healthcare professionals.— @onc_ce (@onc_ce)...

PARP Inhibitors in Ovarian Cancer: Shared Decision-making, Mitigating AEs, & Managing Disparities in Access

Oct 2, 2022 | Ovarian

2) @onc_ce is your ONLY source for serialized #accredited CE/#CME #tweetorials in #oncology. This program is supported by an educational grant from GSK plc and is intended for healthcare professionals. Accreditation statement and faculty disclosures at...

A Scientific Analysis and Clinical Trial Review of PARP Inhibitors for the Maintenance Treatment of Patients with Advanced Ovarian Cancer

Sep 18, 2022 | Ovarian

2) @onc_ce is your ONLY source for serialized #accredited CE/#CME #tweetorials in #oncology. This program is supported by an educational grant from GSK plc and is intended for healthcare professionals. Accreditation statement and faculty disclosures at...